Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 290
6
Diseases
6
Unique genes
0.315
Avg. similarity score
Common arterial trunk with aortic dominance
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Common arterial trunk with aortic dominance
Common arterial trunk with pulmonary dominance and interrupted aortic arch
Chromosome 22q11.2 microduplication syndrome
Conotruncal anomaly face syndrome
Velocardiofacial syndrome
GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetes
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Common arterial trunk with aortic dominance | 5 | 5 | 2 |
| Common arterial trunk with pulmonary dominance and interrupted aortic arch | 5 | 5 | 2 |
| Chromosome 22q11.2 microduplication syndrome | 4 | 4 | 1 |
| Conotruncal anomaly face syndrome | 4 | 4 | 1 |
| Velocardiofacial syndrome | 4 | 4 | 5 |
| GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetes | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TBX1 | 5 / 6 | Chromosome 22q11.2 microduplication syndrome, Common arterial trunk with aortic dominance, Common arterial trunk with pulmonary dominance and interrupted aortic arch, Conotruncal anomaly face syndrome and 1 more |
| GATA6 | 3 / 6 | Common arterial trunk with aortic dominance, Common arterial trunk with pulmonary dominance and interrupted aortic arch, GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetes |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| MicroRNA (miRNA) biogenesis | Reactome | 1 / 24 | 83.4× | 1.19e-2 | 7.61e-2 |
| Surfactant metabolism | Reactome | 1 / 29 | 69.0× | 1.44e-2 | 8.52e-2 |
| Factors involved in megakaryocyte development and platelet production | Reactome | 1 / 99 | 20.2× | 4.85e-2 | 1.69e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| outflow tract septum morphogenesis | GO:0003148 | 2 / 28 | 222× | 3.24e-5 | 1.29e-3 ✓ sig. |
| negative regulation of transforming growth factor beta2 production | GO:0032912 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| negative regulation of sebum secreting cell proliferation | GO:1904003 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| regulation of animal organ morphogenesis | GO:2000027 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| epithelial cell differentiation | GO:0030855 | 2 / 110 | 56.6× | 5.07e-4 | 9.66e-3 ✓ sig. |
| regulation of antimicrobial humoral response | GO:0002759 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| sebaceous gland cell differentiation | GO:0001949 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| endodermal cell fate determination | GO:0007493 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| vagus nerve morphogenesis | GO:0021644 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| positive regulation of pre-miRNA processing | GO:2000633 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| positive regulation of tongue muscle cell differentiation | GO:2001037 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| animal organ morphogenesis | GO:0009887 | 2 / 130 | 47.9× | 7.07e-4 | 1.21e-2 ✓ sig. |
| positive regulation of cardiac muscle myoblast proliferation | GO:0110024 | 1 / 3 | 1,038× | 9.63e-4 | 1.47e-2 ✓ sig. |
| anatomical structure morphogenesis | GO:0009653 | 2 / 160 | 38.9× | 1.07e-3 | 1.57e-2 ✓ sig. |
| club cell differentiation | GO:0060486 | 1 / 4 | 779× | 1.28e-3 | 1.75e-2 ✓ sig. |